| ANALYSIS OF GAAP VERSUS GAAP EXCLUDING SPECIAL ITEMS DISCLOSURES |
| ||||||||||||
| (Unaudited) |
| ||||||||||||
|
|
| Three Months Ended |
| ||||||||||
|
|
| March 28,
|
| December 28,
|
| March 30,
|
| ||||||
|
|
| (in thousands, except per share data) |
| ||||||||||
| Reconciliation of GAAP gross profit to GAAP gross profit excluding special items: |
|
|
|
|
|
|
| ||||||
| GAAP gross profit |
| $ | 366,437 |
|
| $ | 360,524 |
|
| $ | 340,831 |
|
|
| GAAP gross profit % |
| 65.2 | % |
| 65.4 | % |
| 62.8 | % |
| |||
| Special items: |
|
|
|
|
|
|
| ||||||
| Intangible asset amortization |
| 3,111 |
|
| 3,111 |
|
| 5,008 |
|
| |||
| Cost of COVID-19 response programs |
| 2,025 |
|
| — |
|
| — |
|
| |||
| Total special items |
| 5,136 |
|
| 3,111 |
|
| 5,008 |
|
| |||
| GAAP gross profit excluding special items |
| $ | 371,573 |
|
| $ | 363,635 |
|
| $ | 345,839 |
|
|
| GAAP gross profit % excluding special items |
| 66.1 | % |
| 66.0 | % |
| 63.8 | % |
| |||
| Reconciliation of GAAP operating expenses to GAAP operating expenses excluding special items: |
|
|
|
|
|
|
| ||||||
| GAAP operating expenses |
| $ | 183,090 |
|
| $ | 191,468 |
|
| $ | 183,691 |
|
|
| Special items: |
|
|
|
|
|
|
| ||||||
| Intangible asset amortization |
| 756 |
|
| 756 |
|
| 756 |
|
| |||
| Severance and restructuring |
| 523 |
|
| 2,728 |
|
| 1,744 |
|
| |||
| Other operating expenses (income), net |
| 1,077 |
| (1) | (1) |
|
| — |
|
| |||
| Total special items |
| 2,356 |
|
| 3,483 |
|
| 2,500 |
|
| |||
| GAAP operating expenses excluding special items |
| $ | 180,734 |
|
| $ | 187,985 |
|
| $ | 181,191 |
|
|
| Reconciliation of GAAP net income to GAAP net income excluding special items: |
|
|
|
|
|
|
| ||||||
| GAAP net income |
| $ | 161,190 |
|
| $ | 146,050 |
|
| $ | 130,613 |
|
|
| Special items: |
|
|
|
|
|
|
| ||||||
| Intangible asset amortization |
| 3,867 |
|
| 3,867 |
|
| 5,764 |
|
| |||
| Cost of COVID-19 response programs |
| 2,025 |
|
| — |
|
| — |
|
| |||
| Severance and restructuring |
| 523 |
|
| 2,728 |
|
| 1,744 |
|
| |||
| Other operating expenses (income), net |
| 1,077 |
| (1) | (1) |
|
| — |
|
| |||
| Interest and other expense (income), net |
| (587) |
|
| (1,230) |
|
| (857) |
|
| |||
| Total pre-tax special items |
| 6,905 |
|
| 5,364 |
|
| 6,651 |
|
| |||
| Other income tax effects and adjustments (2) |
| (2,101) |
|
| 317 |
|
| 7,506 |
|
| |||
| Impact of U.S. tax legislation (3) |
| — |
|
| — |
|
| (1,056) |
|
| |||
| GAAP net income excluding special items |
| $ | 165,994 |
|
| $ | 151,731 |
|
| $ | 143,714 |
|
|
|
|
|
|
|
|
|
|
| ||||||
| GAAP net income per share excluding special items: |
|
|
|
|
|
|
| ||||||
| Basic |
| $ | 0.62 |
|
| $ | 0.56 |
|
| $ | 0.53 |
|
|
| Diluted |
| $ | 0.61 |
|
| $ | 0.56 |
|
| $ | 0.52 |
|
|
| Shares used in the calculation of earnings per share excluding special items: |
|
|
|
|
|
|
| ||||||
| Basic |
| 269,003 |
|
| 270,330 |
|
| 273,221 |
|
| |||
| Diluted |
| 271,579 |
|
| 273,269 |
|
| 276,610 |
|
| |||
|
|
|
|
|
|
|
|
| ||||||
| (1) Includes approximately $0.5 million of acquisition-related costs and $0.5 million of cost related to COVID-19 response programs. |
| ||||||||||||
| (2) Includes tax effect of pre-tax special items and miscellaneous tax adjustments. |
| ||||||||||||
| (3) Includes effect of U.S. tax legislation enacted on December 22, 2017. |
| ||||||||||||
|
|
|
|
|
|
|
|
|